#shorts Neuralink neurotechnology braincomputerinterfaces BCI Neuroprosthetics augmentedhuman cyborg Robot Robotics Robots AI artificialintel

[jointhebrigade]

Neuralink has started human clinical trials for their Brain-Computer Interface (BCI) device called N1. The company just secured another $43 million in funding, bringing their total capital raised to more than $320 million. The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) is for patients that have limited or no ability to use both hands due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS). Neuralink says it plans to perform 11 surgeries in 2024, 27 in 2025, 79 in 2026 and more than 22,000 by 2030. Once approved by the FDA, each implant surgery is expected to cost around $40,000 including exams, the device and labor. The company forecasts annual revenue as high as $100 million within five years (2028). In the short-term Neuralink is aiming to treat serious brain diseases, but the eventual goal is to provide human enhancement and achieve "symbiosis with artificial intelligence.” 😳